Simultaneously with the progression of malignant lesions, the expression of CDX2 in GC tissue declines; the expression of CDX2 in early GC is significantly higher than in advanced GC and low status lymphatic and distant metastasis GC. Here, CDX2 is linked to gastric cancer.